2018 annual financial data
Aligos Therapeutics 2018 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -13,661,000 USD and net income was -13,933,000 USD.
Operating cash flow was -6,049,000 USD.
Get free Aligos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -13,661,000 USD
- Net income
- -13,933,000 USD
- Operating cash flow
- -6,049,000 USD